Open an Account
search icon
3
NOTIFICATIONS
Best Algo trading app in India
Bigul

IPCA LABORATORIES LTD. - 524494 - Board Meeting Outcome for Standalone And Consolidated Unaudited Financial Results Along With Limited Review Reports Of The Company'S Statutory Auditors Thereon For The 3Rd Quarter And Nine Months Ended 31St December, 2022.

 Standalone and Consolidated Unaudited Financial Results along with limited review reports of the Company's Statutory Auditors thereon for the 3rd Quarter and nine months ended 31st December, 2022, which was taken on record at the Meeting of the Board of Directors of the Company held today at Mumbai.
14-02-2023
Bigul

IPCA LABORATORIES LTD. - 524494 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

 We wish to inform you that a Conference Call to discuss the Company's Q3FY23 earnings and business update will be held on Thursday, 16th February, 2023 at 16.00 hrs IST.
09-02-2023
Bigul

IPCA LABORATORIES LTD. - 524494 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 Newspaper advertisement published in Business Standard and Nav Shakti regarding petition for sanction of Scheme of Amalgamation of Ramdev Chemical Pvt Ltd. and Tonira Exports Ltd., Company's wholly owned subsidiaries, with the Company.
20-01-2023
Bigul

IPCA LABORATORIES LTD. - 524494 - Board Meeting Intimation for Standalone And Consolidated Unaudited Financial Results For The 3Rd Quarter And Nine Months Ended 31St December, 2022.

 IPCA LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2023 ,inter alia, to consider and approve the Standalone and Consolidated Unaudited Financial Results for the 3rd quarter and nine months ended 31st December, 2022.
20-01-2023
Bigul

IPCA LABORATORIES LTD. - 524494 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

 Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended December 31, 2022
11-01-2023

Why do analysts see 40% potential upside for this pharma stock in 6 months?

 With a market valuation of 21,667.40 Cr, IPCA Laboratories is a large-cap company that engages in the pharmaceutical industry.
08-01-2023

Buy IPCA Laboratories; target of Rs 1000: Motilal Oswal

 Motilal Oswal is bullish on IPCA Laboratories recommended buy rating on the stock with a target price of Rs 1000 in its research report dated December 28, 2022.
29-12-2022

Buy IPCA Laboratories; target of Rs 1000: Motilal Oswal

 Motilal Oswal is bullish on IPCA Laboratories recommended buy rating on the stock with a target price of Rs 1000 in its research report dated December 28, 2022.
29-12-2022
Bigul

IPCA LABORATORIES LTD. - 524494 - Closure of Trading Window

 It is hereby notified that the trading window for dealing in the securities of the Company by the insiders as defined under the SEBI (Prohibition of Insider Trading) Regulations, 2015 shall remain closed with effect from close of business hours on 31st December, 2022 and until 48 hours after the declaration of the Company's unaudited financial results for the 3rd quarter and nine months ended 31st December, 2022 of the financial year 2022-23.
26-12-2022
Bigul

IPCA LABORATORIES LTD. - 524494 - Announcement under Regulation 30 (LODR)-Acquisition

 Acquisition of further 6.53% of the paid-up equity share capital of M/s. Trophic Wellness Pvt. Ltd. (TWPL)
19-12-2022
Next Page
Close

Let's Open Free Demat Account